Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

被引:135
|
作者
Zhou, Jian
Sun, Huichuan
Wang, Zheng
Cong, Wenming
Zeng, Mengsu
Zhou, Weiping
Bie, Ping
Liu, Lianxin
Wen, Tianfu
Kuang, Ming
Han, Guohong
Yan, ZhiPing
Wang, Maoqiang
Liu, Ruibao
Lu, Ligong
Ren, Zhenggang
Zeng, ZhaoChong
Liang, Ping
Liang, Changhong
Chen, Min
Yan, Fuhua
Wang, Wenping
Hou, Jinlin
Ji, Yuan
Yun, Jingping
Bai, Xueli
Cai, Dingfang
Chen, Weixia
Chen, Yongjun
Cheng, Wenwu
Cheng, Shuqun
Dai, Chaoliu
Guo, Wenzhi
Guo, Yabing
Hua, Baojin
Huang, Xiaowu
Jia, Weidong
Li, Qiu
Li, Tao
Li, Xun
Li, Yaming
Li, Yexiong
Liang, Jun
Ling, Changquan
Liu, Tianshu
Liu, Xiufeng
Lu, Shichun
Lv, Guoyue
Mao, Yilei
Meng, Zhiqiang
机构
[1] Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai
[2] Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai
[3] Department of Pathology, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai
[4] Department of Hepatobiliary and Spleenary Surgery, The Affiliated Shengjing Hospital, China Medical University, Shenyang
[5] Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai
[6] Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou
[7] The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai
[8] Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou
[9] Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing
[10] Graduate School, Beijing University of Chinese Medicine, Beijing
[11] Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin
[12] Department of Hepatic Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei
[13] Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu
[14] Department of Oncology, West China Hospital, Sichuan University, Chengdu
[15] Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou
[16] Department of General Surgery, Qilu Hospital, Shandong University, Jinan
[17] Department of Liver Diseases and Digestive Interventional Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an
[18] The First Hospital of Lanzhou University, Lanzhou
[19] Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai
[20] Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang
[21] Department of Interventional Radiology, Chinese PLA General Hospital, Beijing
[22] Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
[23] Department of Interventional Radiology, The Tumor Hospital of Harbin Medical University, Harbin
[24] Department of Oncology, Peking University International Hospital, Beijing
[25] Department of Interventional Oncology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou
[26] Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai
[27] Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai
[28] Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai
[29] Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing
[30] Department of Medical Oncology, PLA Cancer Center, Nanjing Bayi Hospital, Nanjing
[31] Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou
[32] Institute and Hospital of Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese PLA General Hospital, Beijing
[33] Editorial Department of Chinese Journal of Digestive Surgery, Chongqing
[34] Department of General Surgery, The First Hospital of Jilin University, Jilin
[35] Department of Radiology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
[36] Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing
[37] Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai
[38] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai
[39] Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Nanfang Hospital Southern Medical University, Guangzhou
[40] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning
[41] Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai
[42] Department of Interventional Radiology the First Affiliated Hospital of Xinjiang Medical University, Urumqi
[43] Department of Pathology, Tumor Prevention and Treatment Center, Sun Yat-sen University, Guangzhou
[44] Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai
[45] Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine Zhejiang University, Hangzhou
[46] Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin
[47] Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai
[48] Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an
[49] Department of Radiology, West China Hospital of Sichuan University, Chengdu
[50] Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai
关键词
Primary liver cancer; hepatocellular carcinoma; guidelines; China; diagnosis; treatment; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CONTRAST-ENHANCED ULTRASOUND; RANDOMIZED CONTROLLED-TRIAL; STEREOTACTIC BODY RADIOTHERAPY; PREOPERATIVE TRANSARTERIAL CHEMOEMBOLIZATION; SIROLIMUS-BASED IMMUNOSUPPRESSION; VS. RADIOFREQUENCY ABLATION; SURGICAL RESECTION; OPEN-LABEL;
D O I
10.1159/000530495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Primary liver cancer, around 75%-85% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people.Summary: Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China in June 2017, which were updated by the National Health Commission in December 2019, additional high-quality evidence has emerged from researchers worldwide regarding the diagnosis, staging, and treatment of liver cancer, that requires the guidelines to be updated again. The new edition (2022 Edition) was written by more than 100 experts in the field of liver cancer in China, which not only reflects the real-world situation in China, but also may re-shape the nationwide diagnosis and treatment of liver cancer. Key Messages: The new guideline aims to encourage the implementation of evidence-based practice, and improve the national average five-year survival rate for patients with liver cancer, as proposed in the "Health China 2030 Blueprint."
引用
收藏
页码:405 / 444
页数:40
相关论文
共 50 条
  • [1] Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition)
    Qin, Shukui
    CHINESE CLINICAL ONCOLOGY, 2012, 1 (01)
  • [2] Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
    Zhou, Jian
    Sun, Hui-Chuan
    Wang, Zheng
    Cong, Wen-Ming
    Wang, Jian-Hua
    Zeng, Meng-Su
    Yang, Jia-Mei
    Bie, Ping
    Liu, Lian-Xin
    Wen, Tian-Fu
    Han, Guo-Hong
    Wang, Mao-Qiang
    Liu, Rui-Bao
    Lu, Li-Gong
    Ren, Zheng-Gang
    Chen, Min-Shan
    Zeng, Zhao-Chong
    Liang, Ping
    Liang, Chang-Hong
    Chen, Min
    Yan, Fu-Hua
    Wang, Wen-Ping
    Ji, Yuan
    Cheng, Wen-Wu
    Dai, Chao-Liu
    Jia, Wei-Dong
    Li, Ya-Ming
    Li, Ye-Xiong
    Liang, Jun
    Liu, Tian-Shu
    Lv, Guo-Yue
    Mao, Yi-Lei
    Ren, Wei-Xin
    Shi, Hong-Cheng
    Wang, Wen-Tao
    Wang, Xiao-Ying
    Xing, Bao-Cai
    Xu, Jian-Ming
    Yang, Jian-Yong
    Yang, Ye-Fa
    Ye, Sheng-Long
    Yin, Zheng-Yu
    Zhang, Bo-Heng
    Zhang, Shui-Jun
    Zhou, Wei-Ping
    Zhu, Ji-Ye
    Liu, Rong
    Shi, Ying-Hong
    Xiao, Yong-Sheng
    Dai, Zhi
    LIVER CANCER, 2018, 7 (03) : 235 - 260
  • [3] Interpretation of guidelines for the diagnosis and treatment of primary liver cancer (2019 edition) in China
    Qiu, Guoteng
    Jin, Zhaoxing
    Chen, Xin
    Huang, Jiwei
    GLOBAL HEALTH & MEDICINE, 2020, 2 (05): : 306 - 311
  • [4] Guidelines for diagnosis and treatment of advanced breast cancer in China (2022 edition)
    Xu, Binghe
    Ma, Fei
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (02): : 107 - 127
  • [5] Interpretation of the updates of the Chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition)
    Su, Hao
    Wei, Yongguang
    Liao, Xiwen
    Zhu, Guangzhi
    Peng, Minhao
    Fan, Fang
    Peng, Tao
    HEPATOMA RESEARCH, 2024, 10
  • [6] DIAGNOSIS AND TREATMENT OF PRIMARY-CANCER OF THE LIVER
    NIKHINSON, RA
    VOPROSY ONKOLOGII, 1984, 30 (05) : 82 - 84
  • [7] The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition
    Honma, Naoko
    Yoshida, Masayuki
    Kinowaki, Keiichi
    Horii, Rie
    Katsurada, Yuka
    Murata, Yuya
    Shimizu, Ai
    Tanabe, Yuko
    Yamauchi, Chikako
    Yamamoto, Yutaka
    Iwata, Hiroji
    Saji, Shigehira
    BREAST CANCER, 2024, 31 (01) : 8 - 15
  • [8] The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition
    Naoko Honma
    Masayuki Yoshida
    Keiichi Kinowaki
    Rie Horii
    Yuka Katsurada
    Yuya Murata
    Ai Shimizu
    Yuko Tanabe
    Chikako Yamauchi
    Yutaka Yamamoto
    Hiroji Iwata
    Shigehira Saji
    Breast Cancer, 2024, 31 : 8 - 15
  • [9] Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition)
    Liu, Xiufeng
    Xia, Feng
    Chen, Yue
    Sun, Huichuan
    Yang, Zhengqiang
    Chen, Bo
    Zhao, Ming
    Bi, Xinyu
    Peng, Tao
    Ainiwaer, Aizier
    Luo, Zhiwen
    Wang, Fusheng
    Lu, Yinying
    LIVER RESEARCH, 2024, 8 (02) : 61 - 71
  • [10] Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update
    Cong, Wen-Ming
    Bu, Hong
    Chen, Jie
    Dong, Hui
    Zhu, Yu-Yao
    Feng, Long-Hai
    Chen, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (42) : 9279 - 9287